TICKERNOMICS Sign up
Last Update: 2024-12-27 15:29:40
AETHLON MEDICAL INC ( AEMD ) https://www.aethlonmedical.com
0.59USD
Sector:
Healthcare
Industry:
Medical Devices
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
27.80%
-73.05%
AEMD
SPY
32.66%
-97.16%
AEMD
SPY
108.59%
-93.61%
AEMD
SPY
302.52%
-99.97%
AEMD
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
8.19
-6850.09
3.22
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-0.73
9.58
1.36
-272.42
0.00
648.22
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
0.00
0.00
0.00
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
13.1888
0.16
-81.96
2.41
Other Earnings and Cash Flow Stats:
AETHLON MEDICAL INC ( AEMD ) Net Income TTM ($MM) is -11.27
AETHLON MEDICAL INC ( AEMD ) Operating Income TTM ($MM) is -11.58
AETHLON MEDICAL INC ( AEMD ) Owners' Earnings Annual ($MM) is -12.52
AETHLON MEDICAL INC ( AEMD ) Current Price to Owners' Earnings ratio is -0.43
AETHLON MEDICAL INC ( AEMD ) EBITDA TTM ($MM) is -11.23
AETHLON MEDICAL INC ( AEMD ) EBITDA Margin is 0.00%
Capital Allocation:
AETHLON MEDICAL INC ( AEMD ) has paid 0.00 dividends per share and bought back -11.453946 million shares in the past 12 months
AETHLON MEDICAL INC ( AEMD ) has reduced its debt by 0.279736 million USD in the last 12 months
Capital Structure:
AETHLON MEDICAL INC ( AEMD ) Interest-bearing Debt ($MM) as of last quarter is 0
AETHLON MEDICAL INC ( AEMD ) Annual Working Capital Investments ($MM) are -2
AETHLON MEDICAL INC ( AEMD ) Book Value ($MM) as of last quarter is 6
AETHLON MEDICAL INC ( AEMD ) Debt/Capital as of last quarter is 13%
Other Balance Sheet Stats:
AETHLON MEDICAL INC ( AEMD ) has 6 million in cash on hand as of last quarter
AETHLON MEDICAL INC ( AEMD ) has 2 million of liabilities due within 12 months, and long term debt 0 as of last quarter
AETHLON MEDICAL INC ( AEMD ) has 13 common shares outstanding as of last quarter
AETHLON MEDICAL INC ( AEMD ) has 0 million USD of preferred stock value
Academic Scores:
AETHLON MEDICAL INC ( AEMD ) Altman Z-Score is -26.99 as of last quarter
AETHLON MEDICAL INC ( AEMD ) Piotroski Score is 2.00 as of last quarter
Corporate Governance:
AETHLON MEDICAL INC ( AEMD ) largest shareholder is Geode Capital Management, LLC owning 98394 shares at 0.06 ($MM) value
BROENNIMAN EDWARD G(an insider) Executed Type F Transaction for -2430 shares of AETHLON MEDICAL INC ( AEMD ) for the amount of $3547.80 on 2022-03-31
0.54% of AETHLON MEDICAL INC ( AEMD ) is held by insiders, and 3.09% is held by institutions
AETHLON MEDICAL INC ( AEMD ) went public on 2001-01-02
Other AETHLON MEDICAL INC ( AEMD ) financial metrics:
FCF:-8.92
Unlevered Free Cash Flow:-11.20
EPS:-0.81
Operating Margin:0.00
Gross Profit Margin:0.00
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-186.54
Beta:2.41
Buffet's Owners Earnings:-12.52
Price to Owner's Earnings:-0.43
About AETHLON MEDICAL INC ( AEMD ) :
Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.